TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial.

John C Byrd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.